New York University Medical Center
Coapsys device acutely reduces functional ischemic mitral regurgitation
Published in MD Week, January 20th, 2006
Functional ischemic MR "frequently arises after myocardial infarction; it is characterized by annular enlargement or lateral displacement of the subvalvular apparatus," thoracic surgeons in the United States explained.
"Coapsys is a ventricular-annular remodeling device designed to treat functional ischemic MR; it does not require cardiopulmonary bypass," noted E.A. Grossi and colleagues working at the New York University Medical Center. In a paper published in the Annals of Thoracic Surgery, they presented the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of MD Week
Source: MD Week (2006-01-20)
More Articles from MD Week
- DR Systems
Diagnostic imaging company lands new PACS contracts worth nearly $5 million - Finance
American Physicians Capital completes stock repurchase authorization - Hoana Medical
Medical device maker closes $10.2 million in series C financing - Aarhus University Hospital
Fever of unknown origin associated with cancer - Cathay General Hospital, Taipei
Subclavian vein catheterization has high success rate, even in high-risk patients - Ceragenix Pharmaceuticals, Inc.
Antimicrobial medical device coating shows promise in preventing bacterial colonization - More from this issue of MD Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
